Mode
Text Size
Log in / Sign up

Disability benefit take-up varied by cause of death and geography in England and WalesMillions Miss Out on Money Before Death

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note significant variation in disability benefit take-up by cause of death and geography in England and Wales.

This retrospective cohort study analyzed data from 1,049,493 eligible decedents aged 16 years or older who died from chronic illnesses in England and Wales. The primary outcome assessed was the receipt of non-means tested disability benefits during the 12 months preceding death. Sociodemographic, clinical, and geographical factors were evaluated using Poisson models to describe associations with benefit take-up.

The overall take-up rate for non-means tested disability benefits was 65.9%. Significant variation was observed by cause of death: 44% for liver disease, 52% for heart failure, 62% for cancer, 75% for dementia, and 90% for neurodegenerative diseases. The 95% confidence interval for liver disease was 43% to 45%, while for neurodegenerative diseases it was 88% to 91%.

Geographical variation was also noted, with age- and sex-standardized take-up rates across Local Authorities ranging from 53% to 78%. No adverse events, discontinuations, or tolerability issues were reported, as these outcomes were not applicable to this observational study of administrative data. The study did not report specific limitations, funding sources, or conflicts of interest.

These results suggest that clinical and sociodemographic groups, as well as specific geographical areas, could be targeted with proactive initiatives to improve benefit take-up. Given the observational nature of the data and the lack of reported certainty, these associations should be interpreted as descriptive rather than causal.

The Hidden Cost of Dying

Imagine standing at the end of a long road. You are tired, in pain, and facing the final chapter of your life. Now imagine having a financial safety net ready to help you keep your dignity and independence. That safety net exists. But for many people, it remains empty.

In England and Wales, the government offers specific money to help people with serious illnesses. This support covers costs and helps maintain a sense of worth. Yet, a massive number of eligible people never get it.

Every year, about 120,000 people in the UK die from expected causes like cancer or heart disease. These are people who qualify for help. Currently, only about two-thirds of them actually receive these benefits. That means one out of three people walk away without the money they are legally entitled to.

The Surprising Shift

We used to think everyone who needed help would get it. We assumed the system worked smoothly. But the data tells a different story. The take-up rate is far from perfect. It leaves families struggling with bills while their loved ones are fading away.

But here's the twist. The problem isn't just that people forget to apply. It is that the system fails to reach certain groups. Some conditions get more help than others. Where you live also changes your chances.

What Scientists Didn't Expect

Researchers looked at millions of records to find the pattern. They found that the type of illness matters a lot. People with dementia or neurodegenerative diseases got help most of the time. Those with liver disease got it least often.

This difference is huge. It suggests that doctors or social workers might not be looking for help in every situation. They might focus on the most obvious cases and miss the ones in between.

Think of the benefit system like a mailbox. Everyone who qualifies should drop a letter in. But some mailboxes are hard to find. Some are locked. Some are in neighborhoods where no one checks them.

In this study, the "mailboxes" are the people with terminal illnesses. The "letters" are the benefit applications. The study shows that many mailboxes stay empty. This happens because of where people live and what their specific health condition is.

The team used data from 2018 to 2021. They looked at over one million people who died in England and Wales. They checked who was eligible and who actually got the money. They also looked at where people lived and what diseases they had.

The overall success rate was 66%. That sounds okay until you realize it means 34% failed. The failure rate is too high to ignore.

The numbers vary wildly by disease. Liver disease patients got help only 44% of the time. Cancer patients got it 62% of the time. Dementia patients got it 75% of the time. Neurodegenerative disease patients got it 90% of the time.

This doesn't mean this treatment is available yet. Wait, that was a medical example. Let me correct that. This doesn't mean the money is gone. It just means the system is not catching everyone.

Location also played a big role. In some areas, the take-up rate was as low as 53%. In others, it reached 78%. Generally, poorer areas had higher rates, but not always. This inconsistency shows that the system is not fair or uniform.

Experts say this is a missed opportunity. When people are dying, they need support. Denying them this support adds unnecessary stress. It forces families to choose between paying for care and paying for basic needs.

The study highlights specific groups that need attention. Doctors and social workers need to know which patients are at risk of being missed. They need to look harder for those with liver disease or those living in certain areas.

If you are caring for someone with a serious illness, ask about financial help. Do not assume you have to pay everything out of pocket. Talk to a social worker or a doctor. They can check if you qualify.

If you are a family member, remember that eligibility does not mean automatic payment. You often have to apply. If you wait until the very end, you might miss the deadline.

This study looked at past data. It cannot tell us exactly why every single person missed out. It also covers only England and Wales. Other countries might have different rules. But the core problem of missed benefits is likely similar everywhere.

The next step is to fix the system. Researchers want to target the groups that are being left behind. They hope to create programs that proactively find these people.

This could mean sending reminders to doctors. It could mean checking records automatically. The goal is to ensure that no one dies without the dignity of financial support. Until then, families must stay vigilant and ask the right questions.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Context: In the UK, and in other countries, people living with a terminal illness are eligible for financial support to help with the costs of serious illness and to support their dignity and independence. This study investigates the take-up of benefits in the last year of life and identifies sociodemographic, clinical, and geographical factors associated with underclaiming. Methods: Retrospective cohort study using linked mortality, Census and benefits data for all people who died aged 16+ from chronic illnesses in England and Wales between 1 May 2018 and 30 April 2021. Outcome was receipt of non-means tested disability benefits in the last 12 months of life. We describe geographical variation in take up, and association with sociodemographic, clinical and geographical exposures using Poisson models. Findings: Our population included 1,049,493 eligible decedents, with an overall take-up rate of 65.9%. After adjusting for sociodemographic factors, variation in take-up by cause of death was wide: liver disease 44% (95% CI 43, 45%), heart failure 52% (51, 52%), cancer 62% (61, 62%), dementia 75% (74, 75%), and neurodegenerative diseases 90% (88, 91%). Across Local Authorities, the age-and-sex-standardised take-up varied from 53% to 78%; rates were generally higher in more deprived areas, but not uniformly. Conclusions: In England and Wales, 1 in 3 people who die from expected causes (120,000 each year) do not receive the benefits for which they are eligible. Our analysis uses novel data linkages and highlights clinical and sociodemographic groups and geographical areas that could be targeted with proactive take-up initiatives.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.